By Matt Grossman

 

Thermo Fisher Scientific Inc. has received an emergency-use authorization from the U.S. Food and Drug Administration to perform Covid-19 testing on saliva samples collected with its Spectrum Solutions SpectrumDNA SDNA-1000 device, the company said Monday.

The device can allow laboratories to process 8,000 samples in a day, Thermo Fisher said. The company's senior medical director for genetic testing, Manoj Gandhi, said the authorization could help labs meet high demand.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

October 18, 2021 08:33 ET (12:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Thermo Fisher Scientific Charts.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Thermo Fisher Scientific Charts.